Abstract

Short Communication

RBD targeted COVID vaccine and full length spike-protein vaccine (mutation and glycosylation role) relationship with procoagulant effect

Luisetto M*, Tarro G, Farhan Ahmad Khan, Khaled Edbey, Mashori GR, Yesvi AR and Latyschev OY

Published: 26 April, 2021 | Volume 5 - Issue 1 | Pages: 001-008

Related COVID vaccine production many different strategies was followed by the producers.

Observing some rare event of thrombosis after some COVID-19 vaccination, it is interesting to verify if the Target used for the manufacturing can be involved in a different procoagulant activity or not.

Some vaccine are suspended in some country or under a deep new verify- investigation by the regulatory agency. (EU or USA).

This fact it is relevant.

The target SPIKE-PROTEIN FULL LENGTH modified or not or towards the RBD domain can be a relevant factor.

Read Full Article HTML DOI: 10.29328/journal.jcavi.1001007 Cite this Article Read Full Article PDF

Keywords:

RBD domain; Spike full length; Mutation; Glycosilation; COVID-19 vaccine; ADR; Thrombosys

References

  1. Dai L, Gao GF. Viral targets for vaccines against COVID-19. Nat Rev Immunol. 2020; 21: 73–82. PubMed: https://pubmed.ncbi.nlm.nih.gov/33340022/
  2. Speiser DE, Bachmann MF. Vaccines COVID-19: Mechanisms of Vaccination and Immunity. Vaccines. 2020; 8: 404. PubMed: https://pubmed.ncbi.nlm.nih.gov/32707833/
  3. Prüβ BM. Review Current State of the First COVID-19 Vaccines. Vaccines 9010030. 2021; 9: 30. PubMed: https://pubmed.ncbi.nlm.nih.gov/33429880/
  4. Yang J, Wang W, Wei X. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature. 2020; 586: 572–577. PubMed: https://pubmed.ncbi.nlm.nih.gov/32726802/
  5. Liu Z, Xu W, Xia S, Gu C, Wang X, et al. RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response. Signal Transduct Target Ther. 2020; 5: 282. PubMed: https://pubmed.ncbi.nlm.nih.gov/33247109/
  6. Zhang S, Liu Y, Wang X, Yang L, Li H, et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol. 2020; 13: 120. PubMed: https://pubmed.ncbi.nlm.nih.gov/32887634/
  7. Makowski L, Olson-Sidford W, Weisel JW. Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike-protein. Viruses. 2021; 13: 146. PubMed: https://pubmed.ncbi.nlm.nih.gov/33498225/
  8. Brun J, Vasiljevic S, Gangadharan B, Hensen M, Chandran AV, et al. Analysis of SARS-CoV-2 spike glycosylation reveals shedding of a vaccine. 2020.
  9. Watanabe Y, Mendonça L, Allen RE, Howe A, Lee M, et al. Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222. Vaccine. 2021. PubMed: https://pubmed.ncbi.nlm.nih.gov/33501433/ 
  10. Ikegame S, Siddiquey MNA, Hung CT, Haas G, Brambilla L, et al. Qualitatively distinct modes of Sputnik V vaccine-neutralization escape by SARS-CoV-2 Spike variants. medRxiv. 2021. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020991/
  11. Folegatti PM. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomized controlled trial. 2020; 396: 467-478.
  12. Forni G, Mantovani A, COVID-19 Commission of Accademia Nazionale dei Lincei, Rome. COVID-19 vaccines: where we stand and challenges ahead. Cell Death Differ. 2021; 28: 626–639. PubMed: https://pubmed.ncbi.nlm.nih.gov/33479399/
  13. Luisetto M, Almukhtar N, Hamid GA, Khan FA. Spike sars-cov-2 protein as procoagulant factor and vaccine class effect hypothesis. 2021. https://www.researchgate.net/publication/350721725_SPIKE_SARS-COV-2_PROTEIN_AS_PROCOAGULANT_FACTOR_AND_VACCINE_CLASS_EFFECT_HYPOTHESIS
  14. Dai L, Gao GF. Viral targets for vaccines against COVID-19. Nat Rev Immunol. 2020; 21: 73–82. PubMed: https://pubmed.ncbi.nlm.nih.gov/33340022/
  15. Tobaiqy M, Elkout H, MacLure K. Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to Eudra Vigilance Database. Vaccines. 2021; 9: 393.
  16. Al-amri SS, Abbas AT, Siddiq LA, Alghamdi A, Sanki MA, et al. Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein. Scientific Reports. 2021; 7: 44875.

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Figure 1

Figure 3

Figure 1

Figure 4

Figure 1

Figure 5

Figure 1

Figure 6

Figure 1

Figure 7

Similar Articles

Recently Viewed

  • Transumbilical Single-incision Hiatal Hernia Repair and Nissen Fundoplication in situs Inversus Totalis: A Rare Case Report
    Qing Cao, Chen Kang, Kang Gu, Yin Peng, Yang Lv, Xu-Zhong Ding and Peng Li* Qing Cao,Chen Kang,Kang Gu,Yin Peng,Yang Lv,Xu-Zhong Ding,Peng Li*. Transumbilical Single-incision Hiatal Hernia Repair and Nissen Fundoplication in situs Inversus Totalis: A Rare Case Report. Adv Treat ENT Disord. 2026: doi: 10.29328/journal.ated.1001017; 10: 001-003
  • Intravenous Leiomyomatosis of the Uterus with Intracardiac Extension
    Tomas Reyes-del Castillo*, Minerva I Hernandez-Rejon, Jose L Ruiz-Pier, Mario Peñaloza-Guadarrama, Carlos E Merinos-Avila, Cristina Juarez-Cabrera, Pedro A del Valle-Maldonado, Sofia Ley-Tapia and Valentín Gonzalez-Flores Tomas Reyes-del Castillo*,Minerva I Hernandez-Rejon,Jose L Ruiz-Pier,Mario Peñaloza-Guadarrama,Carlos E Merinos-Avila,Cristina Juarez-Cabrera,Pedro A del Valle-Maldonado,Sofia Ley-Tapia,Valentín Gonzalez-Flores. Intravenous Leiomyomatosis of the Uterus with Intracardiac Extension. Arch Vas Med. 2025: doi: 10.29328/journal.avm.1001021; 9: 003-007
  • Identification, Molecular Confirmation, and Antibiotic Sensitivity of Bacteria Isolated from Repeat Breeder Cows in Rangpur Division
    Mst. Mousumi Afroj, Md Faruk Islam, Muhammad Mamunur Roshid, Md Shanto Hossain, Md Samiul Tousif, Omiaya Azam Oishi, Subroto Sarma and Begum Fatema Zohara* Mst. Mousumi Afroj,Md Faruk Islam,Muhammad Mamunur Roshid,Md Shanto Hossain,Md Samiul Tousif,Omiaya Azam Oishi,Subroto Sarma,Begum Fatema Zohara*. Identification, Molecular Confirmation, and Antibiotic Sensitivity of Bacteria Isolated from Repeat Breeder Cows in Rangpur Division. Insights Vet Sci. 2025: doi: 10.29328/journal.ivs.1001047; 9: 008-17
  • Adalimumab in the Treatment of Complex Sarcoidosis-related Inflammatory Eye Disease: A Case Series
    Mina Al-Awqati, Supritha Prasad*, Valeria Esparza, Jacqueline Jansz, Wuily Carpio, Christian Ascoli, Huan Chang, Pooja Bhat, Ann-Marie Lobo-Chan and Nadera Sweiss Mina Al-Awqati, Supritha Prasad*, Valeria Esparza, Jacqueline Jansz, Wuily Carpio, Christian Ascoli, Huan Chang, Pooja Bhat, Ann-Marie Lobo-Chan, Nadera Sweiss. Adalimumab in the Treatment of Complex Sarcoidosis-related Inflammatory Eye Disease: A Case Series. Arch Vas Med. 2024: doi: 10.29328/journal.avm.1001018; 8: 001-003
  • Male in Early Adolescence Presenting with Guillain-Barré Syndrome Following BECOV2D Vaccine
    Vinit Suri*, Kanika Suri, Kunal Suri and Priyal Vinit Suri*, Kanika Suri, Kunal Suri, Priyal. Male in Early Adolescence Presenting with Guillain-Barré Syndrome Following BECOV2D Vaccine. J Child Adult Vaccines Immunol. 2023: doi: 10.29328/journal.jcavi.1001010; 7: 001-004

Read More

Most Viewed

Read More

Help ?